Somewhat Favorable Press Coverage Somewhat Unlikely to Impact Utah Medical Products (NASDAQ:UTMD) Share Price

Media stories about Utah Medical Products (NASDAQ:UTMD) have been trending somewhat positive on Monday, Accern reports. The research firm identifies negative and positive news coverage by analyzing more than twenty million news and blog sources. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Utah Medical Products earned a coverage optimism score of 0.21 on Accern’s scale. Accern also assigned news headlines about the medical instruments supplier an impact score of 46.7886987757338 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the stock’s share price in the next few days.

Utah Medical Products (NASDAQ:UTMD) traded up $0.05 during trading hours on Monday, reaching $81.70. 7,793 shares of the company’s stock were exchanged, compared to its average volume of 10,349. The stock has a market capitalization of $303.79, a P/E ratio of 22.19 and a beta of 0.78. Utah Medical Products has a 12 month low of $58.50 and a 12 month high of $83.15.

The business also recently declared a quarterly dividend, which will be paid on Wednesday, January 3rd. Shareholders of record on Friday, December 15th will be paid a dividend of $0.27 per share. The ex-dividend date is Thursday, December 14th. This represents a $1.08 dividend on an annualized basis and a yield of 1.32%. This is an increase from Utah Medical Products’s previous quarterly dividend of $0.27. Utah Medical Products’s dividend payout ratio (DPR) is currently 28.80%.

Separately, BidaskClub raised shares of Utah Medical Products from a “sell” rating to a “hold” rating in a research note on Wednesday, August 9th.

COPYRIGHT VIOLATION NOTICE: “Somewhat Favorable Press Coverage Somewhat Unlikely to Impact Utah Medical Products (NASDAQ:UTMD) Share Price” was published by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are viewing this piece of content on another site, it was illegally stolen and reposted in violation of U.S. and international copyright and trademark law. The legal version of this piece of content can be viewed at https://www.dispatchtribunal.com/2017/12/05/utah-medical-products-utmd-earning-somewhat-favorable-news-coverage-analysis-shows.html.

About Utah Medical Products

Utah Medical Products, Inc (UTMD) is engaged in the business of producing medical devices that are disposable and for hospital use. The Company’s product categories include labor and delivery/obstetrics, including fetal monitoring accessories, Vacuum-Assisted Delivery Systems (VAD), and other labor and delivery tools; neonatal intensive care, including DISPOSA-HOOD, DELTRAN PLUS and GESCO; gynecology/urology/electrosurgery, including LETZ System, FINESSE+ Generator, EPITOME, PATHFINDER PLUS, HOLMIUM LASER FIBRES, LIBERTY System, ENDOCURETTE, TVUS/HSG-Cath and LUMIN, and blood pressure monitoring, including DELTRAN Disposable Pressure Transducer (DPT), and pressure monitoring accessories, components and other molded parts.

Insider Buying and Selling by Quarter for Utah Medical Products (NASDAQ:UTMD)

Receive News & Ratings for Utah Medical Products Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Utah Medical Products Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply